Abstract
Free nucleic acids are elevated in serum or plasma of patients with various cancers and indicate responsiveness to therapy. Circulating nucleosomes in serum and cerebrospinal fluid (CSF) of 45 patients were studied (10 with glioblastoma, 20 with non-acute neurological disorders, 10 with subarachnoid haemorrhage, and five with non-ruptured aneurysms). Patients with recurrent glioblastoma underwent tumour resection and local chemotherapy. Samples were taken before treatment and daily during the first week after surgery. There were no significant differences between pre-therapeutic nucleosome levels in the various patient groups. In patients with glioblastoma treated by surgery and local chemotherapy, levels of serum and CSF nucleosomes increased moderately during the week after surgery. Postoperatively, three of the 10 patients with glioblastoma developed cerebral oedema when CSF levels increased almost 200-fold reaching a maximum on day 3 after surgery in contrast to patients without oedema. Monitoring CSF levels of nucleosomes in patients with glioblastoma may indicate the development of postoperative complications and warrants further investigations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamson C, Kanu OO, Mehta AI et al (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Exp Opin Invest Drugs 18:1061–1083
Behin A, Hoang-Xuan K, Carpentier AF et al (2003) Primary brain tumours in adults. Lancet 361:323–331
Geiger S, Holdenrieder S, Stieber P et al (2006) Nucleosomes in serum of patients with early cerebral stroke. Cerebro Vasc Dis 21:32–37
Geiger S, Holdenrieder S, Stieber P et al (2007) Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol 254:617–623
Holdenrieder S, Stieber P (2009) Clinical use of circulating nucleosomes. Crit Rev Lab Med Sci 46:1–24
Holdenrieder S, Stieber P, Bodenmuller H et al (2001) Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 39:596–605
Holdenrieder S, Stieber P, Pawel J et al (2004) Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clin Cancer Res 10:5981–5987
Kremer A, Wilkowski R, Holdenrieder S et al (2005) Nucleosomes in pancreatic cancer patients during radiochemotherapy. Tumor Biol 26:44–49
Missler UMD, Wiesmann M, Friedrich C et al (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956–1960
Perry J, Chambers A, Spithoff K et al (2007) Gliadel wafers in the treatment of malignant glioma: a systematic review. Curr Oncol 14:189–194
Rainer TH, Wong LKS, Lam W et al (2003) Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 49:562–569
von Eckardstein KL, Reszka R, Kiwit JC (2005) Intracavitary chemotherapy (paclitaxel/carboplatin liquid crystalline cubic phases) for recurrent glioblastoma - clinical observations. J Neurooncol 74:305–309
Wunderlich MT, Ebert AD, Kratz T etal (1999) Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 30:1190–1195
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Holdenrieder, S., Spuler, A., Tischinger, M., Nagel, D., Stieber, P. (2010). Presence of Nucleosomes in Cerebrospinal Fluid of Glioblastoma Patients – Potential for Therapy Monitoring. In: Gahan, P. (eds) Circulating Nucleic Acids in Plasma and Serum. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9382-0_11
Download citation
DOI: https://doi.org/10.1007/978-90-481-9382-0_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9381-3
Online ISBN: 978-90-481-9382-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)